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Objective: To assess decleration and acceleration in the disease 
process in the initial phase of epsilepsy in children with new onset 
tonic-clonic seizures.  
Study design: Hospital based follow up study.  
Setting: Two university hospitals, a general hospital, and a 
children's hospital in the Netherlands.  
Patients: 204 children aged 1 month to 16 years with idiopathic or 
remote symptomatic, newly diagnosed, tonic-clonic seizures, of 
whom 123 were enrolled at time of their first ever seizure; all children were followed 
until the start of drug treatment (78 children), the occurrence of the fourth untreated 
seizure (41 children), or the end of the follow up period of two years (85 untreated 
children).  
Main outcome measures: Analyis of disease pattern from first ever seizure. The 
pattern was categorised as decelerating if the child became free of seizures despite 
treatment being withheld. In cases with four seizures, the pattern was categorised as 
decelerating if successive intervals increased or as accelerating if intervals decreased. 
Patterns in the remaining children were classified as uncertain.  
Results: A decelerating pattern was found in 83 of 85 children who became free of 
seizures without treatment. Three of the 41 children with four or more untreated 
seizures showed a decelerating pattern and eight an accelerating pattern. In 110 
children the disease process could not be classified, mostly because drug treatment 
was started after the first, second, or third seizure. The proportion of children with a 
decelerating pattern (42%, 95% confidence interval 35% to 49%) may be a minimum 
estimate because of the large number of patients with an uncertain disease pattern.  
Conclusions: Though untreated epilepsy is commonly considered to be a progressive 
disorder with decreasing intervals between seizures, a large proportion of children with 
newly diagnosed, unprovoked tonic-clonic seizures have a decelerating disease 
process. The fear that tonic-clonic seizures commonly evolve into a progressive 
disease should not be used as an argument in favour of early drug treatment in children 
with epilepsy.  
 
Key messages 
l     Untreated epilepsy is commonly thought to be a progressive disease 
l     Early treatment, preferably after the first seizure, has been advocated 
l     In at least 42% of children with newly diagnosed tonic-clonic seizures, the disease has a 
decelerating pattern, with successively longer intervals between seizures 
l     The fear that tonic-clonic seizures commonly evolve into a progressive disorder should not be used 
as an argument in favour of early treatment of these children 
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Untreated epilepsy may be thought of as a progressive disorder. 
Such a view has emerged from the observation by Elwes et al that 
untreated epilepsy shows an accelerating pattern.1 They found that 
intervals between successive untreated seizures decreased in many 
patients. In addition, a larger number of seizures before starting 
treatment seemed to be associated with a poorer control of 
seizures.2 If these observations are correct, an aggressive approach 
may be appropriate, as has been advocated by Reynolds et al, who 
advised starting treatment as soon as possible, preferably after the first seizure, to 
prevent the development of intractable epilepsy.3 4 5 Early treatment for all patients with 
newly diagnosed seizures has considerable consequences, however, as all antiepileptic 
drugs have side effects. A randomised trial comparing early and delayed treatment, the 
multicentre study of epilepsy and single seizures, is being conducted by D Chadwick. 
Intervals between seizures may vary. Patients with accelerating patterns–shortening 
intervals between seizures–may be more likely to be referred and treated. The 
retrospective study by Elwes et al 1 was confined to patients for whom the decision to 
start treatment had already been made. Patients with accelerating seizure patterns may 
have been overrepresented, and it is doubtful that these findings could be applied to 
newly diagnosed patients. 
The uncertainty about the clinical course of epilepsy and the possible clinical 
consequences of early treatment of all patients prompted us to study the pattern of 
seizures in a cohort of children with newly diagnosed, unprovoked tonic-clonic seizures. 
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This study is part of the prospective, multicentre Dutch study of 
epilepsy in childhood, which started in 1988. We enrolled all children 
aged 1 month to 16 years with newly diagnosed single seizures or 
epilepsy who had been referred to two university hospitals, a 
general hospital, and a children's hospital in the Netherlands up to 
August 1992. The main aims were to study the prognosis of single 
seizures, the prognosis of newly diagnosed epilepsy, and the 
consequences of early withdrawal of antiepileptic drugs in children 
who responded well to treatment. The study was approved by the medical ethical 
committees of the participating hospitals. Most children were referred directly by their 
general practitioners; some were seen in casualty departments, and some were 
referred by paediatricians. 
A committee of three child neurologists judged whether the description of the ictal 
events fulfilled the predefined descriptive diagnostic criteria adapted from van 
Donselaar et al.6 Children with neonatal, febrile or other acute symptomatic seizures 
were excluded, as were children who were referred from other hospitals. The panel 
assessed the diagnosis of epilepsy, classified the seizures according to the revised 
classification of the International League Against Epilepsy,7 and categorised the 
epilepsies according to the criteria proposed by Gastaut.8 Etiology was classified as 
remote symptomatic or idiopathic.9 Children with single seizures were not treated with 
antiepileptic drugs, but the attending child neurologists were free to start or to delay 
treatment in children presenting with a status epilepticus or in children who had suffered 
two seizures or more. 
Of the 563 children who were enrolled between 1 August 1988 and 1 August 1992, 261 
children had seizures of only the tonic-clonic type, including seizures with partial onset. 
We excluded 57 of these patients because no accurate data on numbers and dates of 
all seizures could be obtained. The remaining 204 children formed our study group; 
table 1 presents their main characteristics. Children enrolled in this study were seen at 
an early stage of their disease. The mean interval between the first ever seizure and 
time of recruitment was 4.5 months for all 563 patients, 1.4 months for the study 
population, and 9.2 months for the 57 children excluded because accurate data were 
lacking. All children were followed until the occurrence of the fourth untreated seizure, 
the start of drug treatment, or the end of the follow up period of two years, whichever 
came first. 
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Table 1  Main characteristics of 563 children with newly 
diagnosed seizures and those with tonic-clonic seizures. 
Figures are number (percentage) of patients unless stated 
otherwise 
Multiple seizures within 24 hours were considered as separate events and a status 
epilepticus as a single event. Disease pattern was categorised as uncertain if the child 
was given drug treatment after the first, second, or third seizure. We classified the 
pattern as decelerating if the child became free of seizures without drugs. In cases with 
four seizures or more the pattern was classified as decelerating if the time intervals 
from the first ever seizure successively increased and as accelerating if the time 
intervals successively decreased. The patterns in all remaining children were classified 
as uncertain. 
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We enrolled 123 children after their first seizure, 41 after two 
seizures, 19 after three seizures, and 21 after four or more seizures. 
Drug treatment was started in 10, 19, 9, and 20 patients, 
respectively, at time of intake. Table 2 presents the number of 
seizures before intake and during follow up. 
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Table 2  Seizures and recurrences in a cohort of 204 children 
with epilepsy 
Table 3 shows seizure patterns as from the first ever seizure. We classified the disease 
pattern as decelerating in 83 patients because they became free of seizures without 
medication: 60 had only one seizure, 15 had only two, and eight had only three. In two 
additional untreated children, whose last seizure occurred too close to the end of the 
follow up period to assess the disease pattern, we classified the disease pattern as 
uncertain. The pattern could not be assessed in an additional 78 children who were 
treated after their first seizure (10 children presenting with a status epilepticus) or their 
second (46 children) or third seizure (22 children). Of the 22 children treated after their 
third seizure, the intervals had decreased in 14 and increased in eight. Of the 41 
patients with four or more untreated seizures, three showed a decelerating pattern, 30 
an erratic pattern (classified as uncertain), and eight an accelerating pattern. In 
summary, the pattern was decelerating in 86 children (42%, 95% confidence interval 35-
49%), uncertain in 110 (54%), and accelerating in eight (4%). 
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Table 3  Timing of seizure patterns in 204 children with 
epilepsy 
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The possibility that untreated epilepsy is a progressive disorder is of 
major importance in balancing the pros and cons of early treatment 
with antiepileptic drugs. Our study shows that in a large proportion 
of children with newly diagnosed, untreated tonic-clonic seizures the 
intervals between successive seizures become longer. This 
proportion may be a low estimate because we could not classify the 
pattern in the substantial number of patients who were given drug 
treatment after the first or subsequent seizures. 
Ideally, the clinical course of epilepsy would be studied in an unselected, untreated 
group of children enrolled at the onset of the disease and followed for a long time 
without treatment, but such a study design is ethically not acceptable at this time. Our 
study reflects clinical practice. We enrolled the patients at an early stage of their 
disease and were rather reluctant to start treatment with antiepileptic drugs. On the 
basis of the catchment area of the participating hospitals and the incidence figures from 
epidemiological studies we estimate that we have enrolled about 75% of the children 
with new onset epilepsy. 
Study design 
The design of our study has some limitations. We confined ourselves to children with 
tonic-clonic seizures (including seizures with partial onset). We expected to get 
accurate data on the number and dates of these events only in this group of children. 
We excluded 57 of the 261 eligible patients because accurate data on some seizures 
were lacking; the mean interval between the first ever seizure and enrolment was much 
longer in these children. If none of these 57 patients had a decelerating pattern (which 
is highly unlikely), the proportion of children with a decelerating pattern would decrease 
to 33%. We thus think that excluding these children did not have a profound impact on 
our main conclusion. 
We included patients enrolled after a single seizure, because some doctors recommend 
treating these patients as soon as possible.5 Moreover, these children can be followed 
prospectively from the onset of their "epilepsy." Had we confined our study to patients 
with at least two seizures (excluding the 60 patients with a first seizure who did not 
have a recurrence without treatment and the 10 patients who were treated after their 
first seizure), the proportion of patients with a decelerating pattern would be much lower 
(19%) but would still be greater than the proportion with an accelerating pattern. 
We defined the occurrence of the fourth untreated tonic-clonic seizure as an end point. 
By that time most children will be receiving treatment with antiepileptic drugs. Moreover, 
the timing of seizures in the early phase will be one of the deciding factors in starting or 
delaying treatment. Determining the proportion of children with an erratic seizure 
pattern would require delaying the start of treatment much longer so that a larger 
number of successive time intervals could be evaluated in each patient–an approach 
that was ethically not acceptable at the time of this study. We believe that our data give 
a fair approximation of the lower limit of the proportion of children with a decelerating 
pattern. 
Study results 
Our results contradict the results of Elwes et al,1 who found an accelerating seizure 
pattern in "many" (59%) patients with untreated tonic-clonic seizures. The group of 
patients that we studied was younger than Elwes et al's cohort. Also, that retrospective 
study was confined to patients in whom the decision to start treatment had already 
been made. The researchers classified the temporal pattern as accelerating if 
successive intervals decreased even if the patient had had only three seizures. With 
similar selection and analysis, 22 of 57 children (39%) in our study had an accelerating 
pattern. This clearly shows that studies using only patients already allocated to 
treatment are biased towards exclusion of patients with decelerating seizure patterns. 
Length of intervals between seizures may fluctuate. The policy to treat all patients 
immediately may obscure the fact that the interval between subsequent seizures may 
be longer, even without drug treatment. Had we treated all our patients at the time of 
recruitment, we would have missed the favourable outcome of a substantial proportion 
of children who became free of seizures without drugs. We might even have been 
convinced that lack of seizures was due to the drugs instead of to the course of their 
epilepsy. Elwes et al probably missed the favourable prognosis in a substantial 
proportion of patients by treating them all at the time of enrollment. 
We believe our findings are a fair approximation of the clinical course of idiopathic or 
remote symptomatic, newly diagnosed, tonic-clonic seizures in childhood. The fear that 
early untreated epilepsy commonly evolves into a progressive disease should not be 
used as an argument in favour of early treatment of these children. 
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